Transgene Biotek Limited (BOM:526139)
2.880
+0.010 (0.35%)
At close: Apr 28, 2026
-24.61% (1Y)
| Market Cap | 218.22M |
| Revenue (ttm) | 2.33M |
| Net Income (ttm) | -19.09M |
| Shares Out | 75.77M |
| EPS (ttm) | -0.25 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 34,593 |
| Average Volume | 47,408 |
| Open | 2.890 |
| Previous Close | 2.870 |
| Day's Range | 2.720 - 2.890 |
| 52-Week Range | 1.830 - 5.260 |
| Beta | 0.72 |
| RSI | 55.80 |
| Earnings Date | May 26, 2026 |